Po-Lan Su

12PUBLICATIONS
25CO-AUTHORS
Molecular targetsPredictive and prognostic markersFluid-structure interaction and aeroacousticsCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 11, 2025
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK-Mutated Lung Cancer: A Real-World Comparative Study.

Chien-Yu Lin, Po-Lan Su, Chin-Wei Kuo

|Oct 23, 2025
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations.

Po-Lan Su, Peiran Xu, Chien-Chung Lin

|Mar 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study.

Qi-An Wang, I-Lin Tsai, Chien-Yu Lin

|Sep 18, 2023
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study.

Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei

|May 15, 2023
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study.

Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu

|Mar 09, 2023
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.

Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin

Pageof 2

Frequent Collaborators

7 joint publications

Chien-Chung Lin

2 joint publications

Chin-Wei Kuo

2 joint publications

Chien-Yu Lin

1 joint publications

Che-Wei Hsu